Registered entities
Axon Therapies Inc
Reg. No. 20201847568United States
Innovation
10 patent families (7 granted) — focus: Human necessities; filing pace slowing. Cited 5,388 times.
| Year | Filings |
|---|---|
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 6 |
| 2023 | 5 |
| 2024 | 7 |
| 2025 | 1 |
Social engagement
Social engagement: 1.6K social following, 6 posts in the last 12 months — below the industry typical range.
Investor mix
6 investors on record; lead investors include Earlybird, Sante.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 83% |
| Bank & private debt | 1 | 17% |
Recent activity
25 Feb 2026
Event
THT2026
11 Dec 2025
Event
CSI Focus D-HF conference
21 Oct 2025
Event
TCT2025